Relapsed/Refractory LBCL

Advertisement
DocWire News EditorsASH Annual Meeting and Exposition 2021 | April 3, 2023
The chimeric antigen receptor (CAR) T-cell therapy lisocabtagene maraleucel (liso-cel) significantly improved event-free ...
Read More
Advertisement
Advertisement
Latest News

April 18, 2025